Immunoassays for topiramate

Details Immunoassays for topiramate Immunoassays for topiramate

2007-09-20

2010-02-02

Haq, Shafiqul (Department: 1641)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C435S007100, C435S007900, C436S533000, C436S536000, C436S544000, C436S546000, C436S815000, C530S403000, C530S408000, C530S388900, C530S389800, C549S200000

Reexamination Certificate

active

07655429

ABSTRACT:
Topiramate analogs have substituents at the sulfamate group, 9-position, or 10-position. Topiramate analogs may include immunogenic moieties to prepare anti-topiramate antibodies, or antigenic moieties for immunodiagnostic assays. Also, the topiramate analog can include tracer moieties for detecting the presence or amount of the analog during an immunodiagnostic assay. Additionally, the topiramate analogs can be used in immunodiagnostic assays to compete with topiramate for binding with anti-topiramate antibodies. Such an immunodiagnostic assay can be used for detecting the presence of topiramate in a sample obtained from a subject previously administered topiramate by the following: combining an anti-topiramate antibody and a topiramate analog with a sample to form a first composition; allowing any free topiramate from the sample and the topiramate analog to compete for binding with the antibody; detecting binding between the topiramate analog and the antibody.

REFERENCES:
patent: 4492762 (1985-01-01), Wang et al.
patent: 4593089 (1986-06-01), Wang et al.
patent: 4668640 (1987-05-01), Wang et al.
patent: 4708929 (1987-11-01), Henderson
patent: 4751190 (1988-06-01), Chiapetta et al.
patent: 4847209 (1989-07-01), Lewis et al.
patent: 5120653 (1992-06-01), Henderson
patent: 5571728 (1996-11-01), Kraus
patent: 5604091 (1997-02-01), Henderson
patent: 5643734 (1997-07-01), Henderson
patent: 5798083 (1998-08-01), Massey et al.
patent: 5834206 (1998-11-01), Neuenhofer et al.
patent: 5952187 (1999-09-01), Stenglein et al.
patent: 6248597 (2001-06-01), Eda et al.
patent: 6448091 (2002-09-01), Massey et al.
patent: 6514770 (2003-02-01), Sorin
patent: 6699840 (2004-03-01), Almarsson et al.
patent: 7060725 (2006-06-01), Abdel-Magid et al.
patent: 7098188 (2006-08-01), Abdel-Magid et al.
patent: 7157589 (2007-01-01), Berkner et al.
patent: 2004/0258758 (2004-12-01), Gustow et al.
patent: WO 2006/047204 (2006-05-01), None
patent: WO 2006/047450 (2006-05-01), None
Office Action dated Apr. 4, 2008, from U.S. Appl. No. 11/254,598, 10 pages.
Christensen, Jakob, et al.; “Liquid Chromatography Tandem Mass Spectrometry Assay for Topiramate Analysis in Plasma and Cerebrospinal Fluid: Validation and Comparison with Fluorescence-Polarization Immunoassay,”Therapeutic Drug Monitoring, 24:658-665; received Nov. 14, 2001; accepted Mar. 27, 2002.
Berry, David J., et al.; “Comparison of Topiramate Concentrations in Plasma and Serum by Fluorescence Polarization Immunoassay,”Therapeutic Drug Monitoring, 22:460-464; received Aug. 2, 1999; accepted Feb. 29, 2000.
Chen, Su, et al.; “Validation of liquid-liquid extraction followed by flow-injection negative ion electrospray mass spectrometry assay to Topiramate in human plasma,”Rapid Communications in Mass Spectrometry, 2001; 15:159-163.
Tang, Peter H., et al.; “An Improved Gas Chromatography Assay for Topiramate Monitoring in Pediatric Patients,”Therapeutic Drug Monitoring, 22:195-201; received Feb. 23, 1999; accepted Sep. 30, 1999.
Mozayani, Ashraf, et al.; “Distribution of Topiramate in a Medical Examiner's Case,”Journal of Analytical Toxicology, vol. 23, Oct. 1999.
Riffitts, J.M., et al.; “A capillary gas chromatographic assay with nitrogen phosphorus detection for the quantification of topiramate in human plasma, urine and whole blood,”Journal of Pharmaceutical and Biomedical Analysis, 19 (1999) 363-371; received Nov. 8, 1996; accepted May 8, 1998.
Faivre-Chauvet et al. Introduction of five potentially metabolizable linking groups between in-cyclohexyl EDTA derivatives and F(ab1)2fragments of anti-carcinoembryonic antigen antibody-II. Comparative pharmacokinetics and biodistribution in human colorectal carcinoma-bearing nude mice. Nucl. Med. Biol. 1993, vol. 20, No. 6, pp. 763-771, abstract and p. 764.
Holland, Mary L., et al.; “Automated capillary gas chromatographic assay using flame ionization for the determination of topiramate in plasma,”Journal of Chromatography, 433 (1988) 276-281; first received May 16, 1988; revised manuscript received Aug. 1, 1988.
Maryanoff, et al., “Anticonvulsant O-Alkyl Sulfamates. 2,3:4,5-Bis-O-(1-methylethylidend)-β-D-fructopyranose Sulfamate and Related Compounds,”J. Med. Chem. (1987), 30, 880-887.
Office Action. Mail Date: Jun. 4, 2007.
Office Action. Mail Date: Nov. 28, 2006.
Office Action. Mail Date: Jun. 6, 2006.
U.S. Appl. No. 11/254,598, filed Oct. 20, 2005, Ouyang et al.
U.S. Appl. No. 11/254,507, filed Oct. 20, 2005, Ouyang et al.
International Preliminary Report on Patentability from PCT/US2005/037698, May 1, 2007, 5 pages.
Written Opinion, from PCT/US2005/037698, Feb. 17, 2006, 4 pages.
International Search Report, from PCT/US2005/037698, Mar. 14, 2006, 2 pages.
International Preliminary Report on Patentability, from PCT/US2005/038257, May 1, 2007, 6 pages.
Written Opinion, from PCT/US2005/038257, May 23, 2006, 5 pages.
International Search Report, from PCT/US2005/038257, Aug. 4, 2006, 2 pages.
Office Action dated Feb. 23, 2007 from U.S. Appl. No. 11/254,507, 3 pages.
Office Action dated Mar. 20, 2006 from U.S. Appl. No. 11/254,507, 10 pages.

Affiliated with

Also associated with

Rating

Immunoassays for topiramate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunoassays for topiramate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoassays for topiramate will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4217304